RESEARCH-USE BIOSIMILAR ANTIBODY
Matuzumab
Monoclonal antibody · IgG1
Matuzumab (EMD 72000) is a humanized anti-EGFR monoclonal antibody that blocks EGFR activation and downstream signaling, inhibits tumor growth. Deglycosylation and the possible elimination of ADCC activity can reduce the in vivo anti-tumor activity of Mattuzumab.
TARGETEGFR
YMonoclonal antibody
CATALOGSC-BS-393
CATALOG NUMBERSC-BS-393
MOLECULAR WEIGHTApprox. 145.5 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Matuzumab (EMD 72000) is a humanized anti-EGFR monoclonal antibody that blocks EGFR activation and downstream signaling, inhibits tumor growth. Deglycosylation and the possible elimination of ADCC activity can reduce the in vivo anti-tumor activity of Mattuzumab.
Matuzumab is a recombinant research-use antibody directed against EGFR.